IPIX as of today IS NOT the IPIX of last year, last month,

New Post Public Reply Private Reply Replies (0) Message Board
petemantx
560
IPIX as of today IS NOT the IPIX of last year, last month, or even last week!!!

Prior to Wednesday the very, very small base of true longs were the only people that were really tuned into the near magical powers that Brilacidin, the best of a new arm of medicine being comprised of defensin mimetics, possessed!

Due to financial constraints, IPIX/Brilacidin was creeping up on medicine thru many successful clinical trials, but these were not the type of advancements that took the public by storm, even though they were quite momentous( as in the pill form of Brilacidin for use in combating IBD (Irritable Bowel Disease).

But Wednesday finally exploded Brilacidin on the big screen of worldwide medicine by way of showing its power in dealing with CV19 in a govt lab test of human lung tissue.

The trading patterns of the past are gone! Sure, the stock will most likely still be quite volatile due to large hedges many believe have been played by some investors betting the company fails, but NOBODY can take away the success of the CV19 lab tests or again hide Brilacidin and IPIX from the eyes of medicine worldwide.

All investors need to quit acting like scared rabbits. Know what you own and be confident that whereas in the past the tail was wagging the dog, IPIX has now become the BIG DOG and never again can it be returned to the shadows.

Brilacidin is now the shining new sun in the world of medicine. Embrace it, take joy in it, and quite worrying about day to day meanderings of the stock price.

The grants are coming, no ifs, ands, or buts. A successful human trial will follow and that is the FINAL test to show Brilacidin will be a life changing drug for CV19, many other areas where Brilacidin will relieve worldwide pain and suffering, and bring GREAT rewards to stock holders. Past trials make those that have been following Brilacidin closely for years believe our chances for success are overwhelmingly high. Remember, this drug was not a hit or miss idea in a lab with a small number of doctors working on it, it was derived after thousands of hours of data being crunched on super computers to make sure all possible bugs in it were worked out prior to its final formulation.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 170

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
Universal Haptics Protocol May Cut Integration Friction

Updated Category News Views 291

A controller rumbling at the wrong moment is a small annoyance, but the plumbing behind that rumble has been a stubborn mess for years. The Haptics Industry Forum's Universal Haptics Protocol 1.0, announced November 17, 2026, is an attempt to clean up that mess with a shared language between software and touch-feedback hardware. This is not the sort of release that sends...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 20

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading
Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 139

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
Unishippers Climbs 18 Slots on 32.4% Sales Growth Run

Updated Category News Views 100

Thirty new franchise units can move the needle fast Unishippers did not inch its way up the Franchise Times Top 400; it put up a number that deserves a hard look. Sales rose 32.4% in 2025, the company added 30 franchise units, and the result was an 18-place jump to No. 81 on the 2026 ranking. In the shipping category, it was named the sales-growth leader. For a business...

Continue Reading
Knotch Bets Brands Need Answers, Not More Web Pages

Updated Category News Views 147

Pages are starting to look like expensive filing cabinets A website that cannot answer an agent may soon be expensive wallpaper. That is the blunt premise behind Knotch's Ace for Agents, launched Nov. 17, 2026, and frankly it lands because plenty of big companies have spent years piling pages atop pages until nobody can tell which claim is current. Knotch is pitching an...

Continue Reading
Apani Adds Kelsun Assets to Its Natural Fiber Platform

Updated Category News Views 118

A materials deal with more chemistry than chest-thumping Seaweed and cotton have landed under one roof, which is a lot more interesting than another apparel brand slapping a green label on ordinary fabric. Apani said November 17 it acquired the assets of Keel Labs, bringing Keel's seaweed-based Kelsun fiber alongside Apani's enhanced cotton-cellulose filament technology....

Continue Reading
Medical School Rejections Carry a Steep Price Tag Too

Updated Category News Views 86

A rejection letter can turn into a remarkably expensive piece of paper. BeMo Academic Consulting's new Medical School Admissions Trends Report argues that the damage from missing medical-school admission goes far beyond bruised confidence: applicants can spend thousands chasing another cycle, lose time entering practice, and, if they never get in, forgo what the report...

Continue Reading
Historic China-Russia-US Summit Aims for Global Stability

Updated Category News Views 15

The Weight of History in Shenzhen When the big players decide to talk face-to-face, it's more than just a photo op. This week in Shenzhen, the leaders of China, Russia, and the United States are doing just that. And let me tell you, it's the kind of gathering that can either stabilize the gears of global politics or grease the wheels of tension. This chinwag isn't just...

Continue Reading
A Decade of Giving: Light the World Initiative's Impact

Updated Category News Views 14

The Red Kiosk Revolution It's not every day that a church initiative pops up in global conversations, but here we are—ten years into the Light the World initiative by The Church of Jesus Christ of Latter-day Saints. What's interesting is how these little kiosks, like silent ambassadors, have become a staple in 145 spots this holiday season, spanning continents. Each...

Continue Reading

Top 5 Most Recently Viewed Articles

Furniture.com Launches $1,500 Giveaway for Back-to-School Fun

Updated Category News Views 154

Exciting Giveaway from Furniture.com Just in Time for School The online marketplace, Furniture.com, is inviting new social media followers to participate in an exciting giveaway allowing one lucky winner to receive a $1,500 gift card. This giveaway is perfect for anyone looking to enhance their living spaces, such as dorms, home offices, or children's rooms. Transforming...

Continue Reading
Kraken Robotics Achieves Unprecedented Growth in Q3 2025

Updated Category News Views 369

Kraken Robotics Inc. Reports Stellar Q3 2025 Results Kraken Robotics Inc. (TSXV: PNG, OTCQB: KRKNF) has recently released its financial results for Q3 2025, showcasing a remarkable growth trajectory. The company reported consolidated revenue of $31.3 million, marking a significant 60% increase from $19.6 million in the same quarter last year. This surge in revenue can be...

Continue Reading
NVIDIA Innovates AI for Robotics and Autonomous Solutions

Updated Category News Views 337

NVIDIA Enhances Robotics and Automation with New AI Models NVIDIA Corp (NASDAQ: NVDA) is making waves in the semiconductor landscape with its latest advancements in artificial intelligence (AI). With a staggering revenue exceeding $113 billion, NVIDIA has announced innovative generative AI models aimed at improving its Omniverse platform. This initiative is focused on...

Continue Reading
Takeda's ENTYVIO: Transforming IBD Treatment and Market Growth

Updated Category News Views 590

ENTYVIO's Impact on IBD Treatment Takeda Pharmaceutical continues to enhance patient care with ENTYVIO, a gut-selective biologic designed specifically for inflammatory bowel disease (IBD) management. With the recent introduction of a subcutaneous formulation, ENTYVIO has improved patient convenience, allowing for easier administration at home. This evolution in treatment...

Continue Reading
Join AM Best's Complimentary Webinar on AI Litigation Strategies

Updated Category News Views 43

AM Best Webinar Overview AM Best, a global leader in insurance credit ratings, is excited to announce a complementary webinar titled “Defending Artificial Intelligence Claims.” This informative session aims to delve into the intricate world of AI-related legal challenges. Key Discussion Points The webinar will take place at 2:00 p.m. (EST) and features a panel of...

Continue Reading